1. What Triggers a Dme Fraud Investigation of a Medicare Supplier?
Federal scrutiny may begin when durable medical equipment (DME) claims show unusual billing patterns, unsupported physician orders, or discrepancies in delivery records.
A contractor audit or rejected claim does not itself establish fraud. The issue is whether investigators suspect inaccurate documentation, improper reimbursement, or intentional wrongdoing.
Medical Necessity and Questionable Physician Orders
Medicare payment depends on more than a physician's signature. Suppliers must satisfy applicable coverage requirements, including medical necessity, proper coding, and required documentation.
Investigators may compare orders for orthotic braces, wheelchairs, or glucose monitors with clinical records and Medicare coverage criteria. Orders generated through telemedicine may receive scrutiny when the treating practitioner's evaluation does not support the prescribed equipment.
Certain items require a face-to-face encounter and a written order prior to delivery (WOPD). CMS has scheduled an expansion of the affected item list for October 28, 2026. The applicable requirements depend on the claim's date of service.
Billing, Delivery, and Referral Patterns
Repeated claims for multiple braces, equipment that beneficiaries never received, or unusually high referral volumes may prompt further investigation.
Reviewers may examine:
Claims for medically unnecessary or undelivered equipment
HCPCS codes that do not match supplied items
Physician orders obtained through marketing or telemedicine arrangements
Payments connected to patient referrals or call centers
Undisclosed ownership or billing arrangements
Unusual claim volumes or reimbursement patterns may trigger a data-based investigation, but statistical outliers alone do not establish fraudulent intent.
A defense review may test the comparison group, coding assumptions, delivery records, and the supplier's billing controls. These findings can help distinguish legitimate differences in patient populations or equipment needs from potentially intentional misconduct.
2. Evidence Used to Investigate Dme Medicare Claims
DME fraud defense requires reconstructing the claim from the initial medical order through equipment delivery and reimbursement.
The records should identify who ordered the equipment, what the supplier delivered, who submitted the claim, and whether the supporting documentation satisfied Medicare requirements.
| Evidence | Investigation or Defense Issue |
|---|---|
| Standard Written Order (SWO) | Prescriber identity, item description, and order date |
| Clinical Records | Medical necessity and coverage eligibility |
| HCPCS Codes and Claims Data | Equipment type, quantity, and billing accuracy |
| Proof of Delivery (POD) | Whether and when equipment reached the beneficiary |
| Telemedicine Records | Patient evaluation and order generation |
| Marketing Contracts | Referral payments and potential kickbacks |
| Ownership and Enrollment Records | Supplier control and authorized billing activity |
Physician Orders, Clinical Records, and Hcpcs Codes
A valid SWO generally must reach the supplier before claim submission. Certain equipment also requires an order before delivery.
Clinical records must support applicable National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), and other payment requirements.
A signed order alone cannot establish coverage eligibility.
CMS discontinued Certificates of Medical Necessity (CMNs) and DME Information Forms (DIFs) for dates of service on or after January 1, 2023. Their absence from newer claims does not establish a documentation violation.
Proof of Delivery, Marketing Contracts, and Ownership Records
Proof of delivery helps establish whether the billed equipment reached the beneficiary. Medicare generally requires suppliers to retain POD documentation for seven years from the date of service.
Shipping confirmations, inventory records, beneficiary communications, and delivery receipts may resolve disputed claims.
Marketing agreements and payment records serve a different purpose. They can show whether compensation reflected legitimate services or potentially unlawful referrals.
Ownership documents, enrollment filings, and system access records also help determine who controlled billing operations. An executive's title alone does not establish personal criminal liability.
3. Federal Fraud Charges and Liability for Dme Suppliers
A DME investigation may involve criminal healthcare fraud, Anti-Kickback Statute violations, civil False Claims Act liability, or Medicare administrative enforcement.
Healthcare Fraud, Conspiracy, and Anti-Kickback Allegations
Under 18 U.S.C. § 1347, healthcare fraud requires a knowing and willful scheme to defraud a healthcare benefit program or obtain its funds through fraudulent representations.
18 U.S.C. § 1349 separately addresses attempts and conspiracies involving covered fraud offenses.
The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), prohibits knowing and willful remuneration intended to induce or reward federally reimbursable business.
Marketing compensation is not automatically unlawful. Investigators must assess the arrangement, actual services, payment terms, intent, and applicable safe harbors. These issues may require a separate kickback investigations analysis.
On October 9, 2026, DOJ announced that medical supply company owner Mark Loftis had received a 14-year prison sentence after a jury convicted him of conspiracy to commit healthcare and wire fraud. The prosecution involved sham medical orders, unlawful referral payments, and fraudulent Medicare, TRICARE, and CHAMPVA claims.
That sentence resulted from a specific completed prosecution. It does not predict the outcome of another DME investigation.
False Claims Act and Medicare Enrollment Consequences
The civil False Claims Act, 31 U.S.C. § 3729, addresses specified knowingly false claims, including conduct involving deliberate ignorance or reckless disregard.
Its knowledge standard differs from the criminal requirements of healthcare fraud. Related disputes may require False Claims Act defense.
Under 42 CFR § 405.371(a)(2), CMS or a Medicare contractor may suspend payments when, after the required consultation with HHS-OIG and DOJ as appropriate, it determines that a credible allegation of fraud exists. The regulation also recognizes good-cause exceptions. A criminal conviction is not required.
DMEPOS supplier standards under 42 CFR § 424.57 separately govern enrollment requirements and billing privileges. Depending on the circumstances, inaccurate enrollment information or supplier-standard violations may lead to additional administrative action.
Payment suspension, overpayment recovery, and enrollment restrictions require separate review of their legal grounds and procedures.
4. Responding to Dme Audits and Federal Investigations
The appropriate response depends on whether the supplier faces a Medicare contractor audit, payment suspension, civil investigation, or federal criminal inquiry.
Each process involves different legal obligations, evidence requests, and procedural deadlines.
Contractor Audits, Payment Suspensions, and Subpoenas
DME Medicare Administrative Contractors (DME MACs) and program-integrity reviewers may request records to verify claim eligibility or identify overpayments.
HHS-OIG, the FBI, and DOJ may investigate suspected criminal conduct. Their involvement changes the risks associated with interviews and document production.
A supplier should review the issuing authority, records requested, response deadline, and available procedures.
Under 42 CFR §§ 405.374–405.375, a supplier may have an opportunity to submit a rebuttal statement concerning a payment suspension. The determination on that rebuttal is not independently appealable.
A payment-suspension rebuttal is different from an appeal of an overpayment determination or enrollment action. Each notice must be examined for its own response procedure and deadline.
Document Preservation and Executive Defense before Charges
Preserving records matters once a supplier receives notice of an audit or investigation.
Relevant materials include physician orders, electronic claims, delivery receipts, marketing contracts, communications, and billing-system access logs.
Deleting records, altering historical documentation, or making unsupported explanations can complicate the defense.
Executives and the supplier may also have different legal interests when investigators question who directed billing, approved payments, or controlled contractors.
A defense attorney can review document demands, interview requests, privilege issues, and individual exposure before records or statements are provided. Broader matters may overlap with healthcare fraud defense.
5. Dme Fraud Investigation Faqs
Can a signed physician order make a DME claim payable by Medicare?
Not by itself. The claim must satisfy applicable medical necessity, coding, ordering, and delivery requirements. Certain equipment also requires a qualifying face-to-face encounter and written order before delivery.
Can a DME supplier owner face charges for a billing contractor's conduct?
Potentially, but ownership alone does not establish criminal liability. Investigators must examine the owner's involvement, knowledge, instructions, financial arrangements, and the elements of the alleged offense.
Can Medicare suspend a DME supplier's payments without a criminal conviction?
Yes. CMS or a Medicare contractor may suspend payments based on credible allegations of fraud under applicable regulations. The supplier should examine the suspension notice, supporting allegations, rebuttal procedures, and any separate enrollment action.
13 Oct, 2026
